Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13225
Title: Neuroendocrine responses to single doses of buspirone in obsessive-compulsive disorder.
Austin Authors: Norman, Trevor R ;Apostolopoulos, M;Burrows, Graham D;Judd, F K
Affiliation: Department of Psychiatry, University of Melbourne, Austin Hospital, Victoria, Australia
Issue Date: 16-May-1994
Publication information: International Clinical Psychopharmacology; 9(2): 89-94
Abstract: Prolactin and cortisol responses to buspirone, a partial serotonin agonist with effects on the 5-HT1A receptor, were measured in 16 patients with DSM-III-R obsessive-compulsive disorder (OCD) and 16 normal controls. No consistent differences were observed between patients and controls with respect to the hormone responses measured. The results suggest that dysfunction of the 5-HT1A receptor is not present in OCD patients. The limitations of buspirone as a specific agonist challenge of the 5-HT1A receptor are discussed. Although data from other studies generally support a serotonin dysfunction in OCD, the question of which specific subtype(s) of receptor remains unanswered.
Gov't Doc #: 8056999
URI: https://ahro.austin.org.au/austinjspui/handle/1/13225
Journal: International clinical psychopharmacology
URL: https://pubmed.ncbi.nlm.nih.gov/8056999
Type: Journal Article
Subjects: Adult
Buspirone.adverse effects.therapeutic use
Female
Humans
Hydrocortisone.secretion
Male
Obsessive-Compulsive Disorder.drug therapy.physiopathology
Prolactin.secretion
Receptors, Serotonin.drug effects
Appears in Collections:Journal articles

Show full item record

Page view(s)

30
checked on Oct 14, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.